Comparative analysis of target volume coverage and liver exposure in high-dose-rate interstitial brachytherapy and in silico MR LINAC-based stereotactic body radiotherapy plans for colorectal liver metastases (2026) Mansoorian S, Hering S, Hofmaier J, Xiong Y, Weingandt H, Rottler M, Walter F, et al. Journal article Reirradiation clinical practice in gastrointestinal abdominal malignancies: an international reirradiation collaborative group (ReCOG) systematic review (2025) Malik NH, Plastaras JP, Corradini S, Dawson LA, Hawkins MA, Salerno KE, Mayo CS, et al. Journal article, Review article Comparison of dose calculation approaches and clinical dose–response in image-guided head&neck brachytherapy of the oral cavity (2025) Schaller S, Strnad V, Schweizer C, Lubgan D, Merten R, Fietkau R, Bert C, Karius A Journal article ACO/ARO/AIO-22 – External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group (2025) Dapper H, Fleischmann M, Tselis N, Diefenhardt M, Hofheinz RD, Weiß C, Grabenbauer GG, et al. Journal article Letter to the Editor: Reply to Topkan et al (2025) Schweizer C, Strnad V Journal article Postoperative brachytherapy alone for 217 patients with early-stage oral cavity squamous cell carcinoma (2025) Schweizer C, Strnad V, Lotter M, Kreppner S, Merten R, Fietkau R, Karius A Journal article The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey (2025) Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, Loessl K, et al. Journal article Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06) (2024) Maier SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A, Fleischmann DF, Büttner M, et al. Journal article Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial (2024) Fink CA, Ristau J, Buchele C, Klüter S, Liermann J, Hoegen-Saßmannshausen P, Sandrini E, et al. Journal article Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases (2024) Ugurluer G, Schneiders FL, Corradini S, Boldrini L, Kotecha R, Kelly P, Portelance L, et al. Journal article